Dr. Garnet Anderson

For the Media

Dr. Garnet Anderson

Dr. Garnet Anderson is director of Fred Hutch's Public Health Sciences Division and an affiliate professor of biostatistics at the University of Washington School of Public Health and Community Medicine. Dr. Anderson's research focuses on women's health.  She helps lead the design and analysis of large-scale trials to give women new ways to prevent and fight disease and improve their quality of life.

Resources for more information

Leadership bio for Garnet Anderson
As the PHS  Director, Anderson will provide scientific leadership to the division, coordinating and initiating collaborations with the other divisions and the overall center leadership.

Overview of Garnet Anderson's Research Focus

Garnet Anderson - Short Bio

Garnet Anderson - Brief Curriculum Vitae
Appointments, affiliations and researcher interests

Public Health Sciences Division
Using large populations as their laboratory, public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.  

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.

Photos

Download

Download photos and view a video of Dr. Garnet Anderson

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.